Who
Chester Stanley Zygmont III
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Revelation Biosciences.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Feb 2023
- Last trade
- 17 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Aug 2026filed 18 Aug 2026 | REVB Revelation BiosciencesBiotechnology | SEC FORM 4 Code A | —208,073 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | REVB Revelation BiosciencesBiotechnology | SEC FORM 4 Code G | —208,073 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | REVB Revelation BiosciencesBiotechnology | SEC FORM 4 Code G | —208,073 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | REVB Revelation BiosciencesBiotechnology | SEC FORM 4 Code A | —208,073 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | REVB Revelation BiosciencesBiotechnology | SEC FORM 4 Code G | —208,073 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | REVB Revelation BiosciencesBiotechnology | SEC FORM 4 Code G | —208,073 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | REVB Revelation BiosciencesBiotechnology | SEC FORM 4 Code F | $15K13,285 at $1.10 | filing |
| 30 Apr 2026filed 1 May 2026 | REVB Revelation BiosciencesBiotechnology | SEC FORM 4 Code F | $15K13,285 at $1.10 | filing |
| 4 Feb 2026filed 5 Feb 2026 | REVB Revelation BiosciencesBiotechnology | SEC FORM 4 Code F | $22K13,100 at $1.65 | filing |
| 4 Feb 2026filed 5 Feb 2026 | REVB Revelation BiosciencesBiotechnology | SEC FORM 4 Code F | $22K13,100 at $1.65 | filing |
| 8 Jan 2026filed 12 Jan 2026 | REVB Revelation BiosciencesBiotechnology | SEC FORM 4 Code A | $70K78,145 at $0.90 | filing |
| 8 Jan 2026filed 12 Jan 2026 | REVB Revelation BiosciencesBiotechnology | SEC FORM 4 Code A | $70K78,145 at $0.90 | filing |
| 29 Oct 2025filed 31 Oct 2025 | REVB Revelation BiosciencesBiotechnology | SEC FORM 4 Code A | $500K390,614 at $1.28 | filing |
| 11 Feb 2025filed 13 Feb 2025 | REVB Revelation BiosciencesBiotechnology | SEC FORM 4 Code A | $58K15,048 at $3.87 | filing |
| 25 Feb 2023filed 28 Feb 2023 | REVB Revelation Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —611 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.